Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_354434303baa62eb937b82bfcf67cc36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45e35ce78aa6c8684454bd03e9f80cff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91e8c77e41a2fd4e7da2237a9f414721 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4545dabfe2d3b046e015569e5c67acd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccd31da277857576da39c3f68a7af7af http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6213bb91d602bc964ff45b3e6ff49cdf |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
filingDate |
2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6639dfd781ab1cb78325ad4fcab6d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d1ec9c67fbe200aa44f30dedc1a790b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44605bf99fb630bfd33ac037fe6360c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13a4816f16b0410959cda5439f7becb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ea5f32427419147dc010e645047150b |
publicationDate |
2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008068584-A2 |
titleOfInvention |
A heterogeneously configured multiparticulate gastrointestinal drug delivery system |
abstract |
This invention relates to a heterogeneously configured multiparticulate drug delivery system for gastrointestinal delivery of at least one or a combination of active pharmaceutical compositions. The system comprises a multiplicity of enterosoluble or gastrosoluble multiparticulates loaded with the active pharmaceutical composition or compositions for the site-specific delivery of said active pharmaceutical composition or compositions to a specific region in the gastrointestinal tract of a human or animal body. The system can be supplied as reconstitutable granules which are reconstituted immediately before oral administration. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011160062-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089492-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580302-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111617262-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111617262-B |
priorityDate |
2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |